Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: BAE Systems, Chemring

(Sharecast News) - ShoreCap termed BAE System's latest interims "a vote of confidence" and reiterated its 'buy' recommendation on the defence contractor's shares on the back of recent weakness. "These results are a vote of confidence for the Group and supports our view that BAE Systems deserves to retain its position as the premium option across our UK defence coverage," they said in a research note sent to clients.

In their opinion, the approximately 10% downdraft in the shares from their late April highs was triggered by the U.S. debt ceiling saga and the failed Wagner mutiny.

But both were now in the rear-view mirror, they said and the macroeconomic landscape remained "favourable" for the engineer.

Among other factors, they called attention to the group's better-than-expected free cash flow during the half of £1,07bn (ShoreCap: £311m).

They also anticipated that they would upgrade their fair value estimate of 1,166.0p on the shares.

Analysts at Berenberg bumped up their target price for shares of Chemring from 360.0p to 370.0p, pointing out the strength of its fundamentals and labelling the shares as their 'top pick' in the UK defence space.

The move followed the aerospace and defence technologies group's decision to unveil a share buyback programme.

In particular, the analysts noted that the company offered the highest margins on its earnings before interest and taxes and lowest leverage in UK defence for 2023.

And Chemring's Roke and Energetics businesses were likely to sustain its top-line growth.

Together, those two units accounted for more than half of group revenue.

They also raised their outer year earnings per share estimates by 5%.

All told, they judged the shares' valuation to be "attractive" in the wake of the 20% de-rating seen over the past year.

That had left the shares trading at 13.8 their estimates for Chemring's earnings in 2024.

Share this article

Related Sharecast Articles

Broker tips: SThree, M&S, Hollywood Bowl
(Sharecast News) - Jefferies cut its target price on SThree on Tuesday after the group's warning highlighted further downside to earnings for UK staffers.
Broker tips: Compass, Moonpig
(Sharecast News) - Analysts at Berenberg raised their target price on food service business Compass Group from 2,460.0p to 2,900.0p on Monday, stating the company was in possession of "all the ingredients for sustained growth".
Broker tips: Greggs, Impax Asset Management
(Sharecast News) - RBC Capital Markets recommended that investors "buy the dip" on Friday as it initiated coverage of bakery chain Greggs with an 'outperform' rating and 3,240.0p price target.
Broker tips: Diageo, SThree
(Sharecast News) - Diageo fizzed higher on Thursday as UBS upgraded the shares to 'buy' from 'sell and hiked the price target to 2,920p from 2,300p, saying it sees upside risks to the US business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.